Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.046x

Based on the latest financial reports, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a cash flow conversion efficiency ratio of 0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥109.83 Million ≈ $16.07 Million USD) by net assets (CN¥2.41 Billion ≈ $352.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Shanghai Shenqi Pharmaceutical Investmen carry for a breakdown of total debt and financial obligations.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai W Ibeda High Tech Group Co Ltd SHG:688071	0.015x
Fubotv Inc NYSE:FUBO	-0.076x
Tegma Gestão Logística S.A SA:TGMA3	0.053x
Community Health Systems Inc NYSE:CYH	-0.073x
BlackRock Energy and Resources Closed Fund NYSE:BGR	0.012x
Cion Investment Corp NYSE:CION	0.886x
Hanjia Design Croup Co Ltd Class A SHE:300746	-0.002x
HiVi Acoustics Technology Co Ltd SHE:002888	0.013x

Annual Cash Flow Conversion Efficiency for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Shanghai Shenqi Pharmaceutical Investmen.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.43 Billion ≈ $355.12 Million	CN¥207.79 Million ≈ $30.41 Million	0.086x	-5.06%
2023-12-31	CN¥2.39 Billion ≈ $349.81 Million	CN¥215.59 Million ≈ $31.55 Million	0.090x	-32.96%
2022-12-31	CN¥2.37 Billion ≈ $347.27 Million	CN¥319.23 Million ≈ $46.71 Million	0.135x	+74.66%
2021-12-31	CN¥2.39 Billion ≈ $350.10 Million	CN¥184.26 Million ≈ $26.96 Million	0.077x	+80.90%
2020-12-31	CN¥2.33 Billion ≈ $340.61 Million	CN¥99.10 Million ≈ $14.50 Million	0.043x	-11.67%
2019-12-31	CN¥2.66 Billion ≈ $389.47 Million	CN¥128.28 Million ≈ $18.77 Million	0.048x	-15.67%
2018-12-31	CN¥2.60 Billion ≈ $380.28 Million	CN¥148.53 Million ≈ $21.73 Million	0.057x	+115.90%
2017-12-31	CN¥2.53 Billion ≈ $370.30 Million	CN¥66.99 Million ≈ $9.80 Million	0.026x	+11200.00%
2016-12-31	CN¥2.43 Billion ≈ $356.31 Million	CN¥570.41K ≈ $83.47K	0.000x	-98.22%
2015-12-31	CN¥2.29 Billion ≈ $334.49 Million	CN¥30.12 Million ≈ $4.41 Million	0.013x	+405.40%
2014-12-31	CN¥2.00 Billion ≈ $292.37 Million	CN¥-8.62 Million ≈ $-1.26 Million	-0.004x	-110.46%
2013-12-31	CN¥1.81 Billion ≈ $265.15 Million	CN¥74.75 Million ≈ $10.94 Million	0.041x	+183.60%
2012-12-31	CN¥226.61 Million ≈ $33.16 Million	CN¥-11.18 Million ≈ $-1.64 Million	-0.049x	-213.50%
2011-12-31	CN¥211.50 Million ≈ $30.95 Million	CN¥-3.33 Million ≈ $-487.11K	-0.016x	-109.17%
2010-12-31	CN¥192.37 Million ≈ $28.15 Million	CN¥33.04 Million ≈ $4.83 Million	0.172x	+309.61%
2009-12-31	CN¥183.43 Million ≈ $26.84 Million	CN¥7.69 Million ≈ $1.13 Million	0.042x	-65.35%
2008-12-31	CN¥208.82 Million ≈ $30.56 Million	CN¥25.26 Million ≈ $3.70 Million	0.121x	+54.40%
2007-12-31	CN¥204.29 Million ≈ $29.89 Million	CN¥16.01 Million ≈ $2.34 Million	0.078x	+344.25%
2006-12-31	CN¥188.49 Million ≈ $27.58 Million	CN¥-6.05 Million ≈ $-884.87K	-0.032x	-118.13%
2005-12-31	CN¥184.92 Million ≈ $27.06 Million	CN¥32.72 Million ≈ $4.79 Million	0.177x	+528.48%
2004-12-31	CN¥176.21 Million ≈ $25.79 Million	CN¥4.96 Million ≈ $725.94K	0.028x	-6.34%
2003-12-31	CN¥150.23 Million ≈ $21.98 Million	CN¥4.52 Million ≈ $660.84K	0.030x	-72.58%
2002-12-31	CN¥146.14 Million ≈ $21.38 Million	CN¥16.02 Million ≈ $2.34 Million	0.110x	+234.59%
2001-12-31	CN¥251.84 Million ≈ $36.85 Million	CN¥-20.51 Million ≈ $-3.00 Million	-0.081x	-209.56%
2000-12-31	CN¥361.16 Million ≈ $52.85 Million	CN¥26.85 Million ≈ $3.93 Million	0.074x	+864.07%
1999-12-31	CN¥336.74 Million ≈ $49.28 Million	CN¥-3.28 Million ≈ $-479.48K	-0.010x	-104.86%
1998-12-31	CN¥363.26 Million ≈ $53.16 Million	CN¥72.67 Million ≈ $10.63 Million	0.200x	--

About Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A

SHG:600613 China Drug Manufacturers - General

Market Cap

$412.42 Million

CN¥2.82 Billion CNY

Market Cap Rank

#13532 Global

#4269 in China

Share Price

CN¥5.88

Change (1 day)

+0.17%

52-Week Range

CN¥5.45 - CN¥7.19

All Time High

CN¥24.35